Modulation of sputum gene expression in COPD by fluticasone/salmeterol

E. R. Sutherland, T. A. Moss, A. D. Stevens, J. Pak, R. J. Martin (Denver, United States Of America)

Source: Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Session: Recent advances in the treatment of COPD and acute lung injury
Session type: Thematic Poster Session
Number: 3844
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. R. Sutherland, T. A. Moss, A. D. Stevens, J. Pak, R. J. Martin (Denver, United States Of America). Modulation of sputum gene expression in COPD by fluticasone/salmeterol. Eur Respir J 2006; 28: Suppl. 50, 3844

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytokine receptors expression in induced sputum in asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018



Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Source: Eur Respir J 2007; 30: 472-478
Year: 2007



The effect of salmeterol/fluticasone propionate (SFC) on bronchial mucosal neutrophils and IL-8 gene expression in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 354s
Year: 2007

Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016


Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
Source: ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018
Year: 2018



Gene expression profiling of induced sputum from COPD patients and healthy smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006

Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007

Assessment of cytokine mRNA expression in patients with COPD exacerbations
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

A sputum gene expression signature predicts oral corticosteroid response in asthma
Source: Eur Respir J, 49 (6) 1700180; 10.1183/13993003.00180-2017
Year: 2017



Long-term use of ICS influence TLR2 expression on induced sputum from severe COPD patients
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012

Increased sputum IL-1β and IL-5 gene expression in exacerbations of COPD demonstrated with real-time PCR
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004

Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003

Chemokines receptors expression in induced sputum in COPD and asthma
Source: Annual Congress 2003 - Activation, migration and death of immune cells
Year: 2003


Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002

Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Effect of salmeterol in asthmatic patients with low sputum eosinophils
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 502s
Year: 2002